Oppenheimer Increases Albemarle (NYSE:ALB) Price Target to $440.00
Oppenheimer Increases Albemarle (NYSE:ALB) Price Target to $440.00
Albemarle ($Albemarle(ALB.US)$) had its price target increased by equities researchers at Oppenheimer from $368.00 to $440.00 in a research report issued on Monday, Stock Target Advisor reports. The brokerage presently has an "outperform" rating on the specialty chemicals company's stock. Oppenheimer's price target suggests a potential upside of 79.84% from the company's current price.
Albemarle($Albemarle(ALB.US)$據Stock Target Advisor報道，在週一發佈的一份研究報告中，奧本海默的股票研究人員將其目標價從368.00美元上調至440.00美元。該經紀公司目前對這家特種化學品公司的股票給予了“跑贏大盤”的評級。奧本海默的目標股價表明，該公司目前的股價可能上漲79.84%。
Several other brokerages have also recently weighed in on ALB. TheStreet raised shares of Albemarle from a "c+" rating to a "b" rating in a research note on Wednesday, May 4th. Wells Fargo & Company raised their price target on shares of Albemarle from $285.00 to $320.00 and gave the stock an "overweight" rating in a research note on Tuesday, May 24th. Jefferies Financial Group reaffirmed a "buy" rating and set a $290.00 price target on shares of Albemarle in a research note on Monday, May 16th. KeyCorp raised shares of Albemarle from an "underweight" rating to a "sector weight" rating in a research note on Wednesday, July 20th. Finally, Cowen raised their price target on shares of Albemarle from $275.00 to $300.00 in a research note on Friday, May 6th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $279.05.
其他幾家券商最近也對ALB發表了看法。華爾街在5月4日星期三的一份研究報告中將Albemarle的股票評級從“c+”上調至“b”。富國銀行將Albemarle股票的目標價從285.00美元上調至320.00美元，並在週二的一份研究報告中給予該股“增持”評級。傑富瑞金融集團在5月16日星期一的一份研究報告中重申了對Albemarle的“買入”評級，併為Albemarle的股票設定了290.00美元的目標價。在7月20日星期三的一份研究報告中，KeyCorp將Albemarle的股票評級從“減持”上調至“行業權重”。最後，考恩在5月6日星期五的一份研究報告中將Albemarle的股票目標價從275.00美元上調至300.00美元。兩名研究分析師對該股的評級為賣出，5名分析師給出了持有評級，12名分析師給出了買入評級。根據MarketBeat的數據，該股目前的共識評級為“適度買入”，共識目標價為279.05美元。
Get Albemarle alerts:
到達阿爾伯瑪爾警報：
Albemarle Price Performance
Albemarle性價比
NYSE ALB opened at $244.66 on Monday. The business has a 50 day simple moving average of $223.22 and a 200 day simple moving average of $216.18. Albemarle has a 52-week low of $169.93 and a 52-week high of $291.48. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.20 and a current ratio of 1.88. The stock has a market cap of $28.66 billion, a price-to-earnings ratio of 110.21, a PEG ratio of 0.45 and a beta of 1.58.
紐約證交所ALB週一開盤報244.66美元。該業務的50日簡單移動均線切入位為223.22美元，200日簡單移動均線切入位為216.18美元。Albemarle的52周低點為169.93美元，52周高位為291.48美元。該公司的負債權益比為0.51，速動比率為1.20，流動比率為1.88。該股市值為286.6億美元，市盈率為110.21倍，市盈率為0.45倍，貝塔係數為1.58。
Albemarle (NYSE:ALB – Get Rating) last posted its earnings results on Wednesday, August 3rd. The specialty chemicals company reported $3.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.79 by $0.66. Albemarle had a return on equity of 15.39% and a net margin of 6.08%. During the same quarter in the previous year, the business posted $0.89 earnings per share. Analysts anticipate that Albemarle will post 20.75 earnings per share for the current fiscal year.
Albemarle(紐約證券交易所代碼：ALB-GET評級)最近一次公佈收益結果是在8月3日星期三。這家特種化學品公司公佈本季度每股收益(EPS)為3.45美元，高於分析師普遍預期的2.79美元和0.66美元。Albemarle的股本回報率為15.39%，淨利潤率為6.08%。在去年同一季度，該業務公佈的每股收益為0.89美元。分析師預計，Albemarle本財年將公佈每股收益20.75美元。
Institutional Investors Weigh In On Albemarle
機構投資者對Albemarle的看法
A number of hedge funds and other institutional investors have recently modified their holdings of the company. Vanguard Group Inc. lifted its holdings in shares of Albemarle by 0.6% during the first quarter. Vanguard Group Inc. now owns 13,661,001 shares of the specialty chemicals company's stock worth $3,021,130,000 after buying an additional 75,867 shares in the last quarter. BlackRock Inc. lifted its holdings in shares of Albemarle by 8.8% during the first quarter. BlackRock Inc. now owns 9,924,312 shares of the specialty chemicals company's stock worth $2,194,761,000 after buying an additional 803,134 shares in the last quarter. State Street Corp lifted its holdings in shares of Albemarle by 0.3% during the first quarter. State Street Corp now owns 5,364,655 shares of the specialty chemicals company's stock worth $1,188,408,000 after buying an additional 16,968 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Albemarle by 3.4% during the fourth quarter. Geode Capital Management LLC now owns 2,145,611 shares of the specialty chemicals company's stock worth $500,283,000 after buying an additional 71,109 shares in the last quarter. Finally, Bank of America Corp DE lifted its holdings in shares of Albemarle by 181.3% during the first quarter. Bank of America Corp DE now owns 1,489,347 shares of the specialty chemicals company's stock worth $329,369,000 after buying an additional 959,810 shares in the last quarter. Institutional investors and hedge funds own 80.03% of the company's stock.
一些對衝基金和其他機構投資者最近調整了對該公司的持股。先鋒集團第一季度增持Albemarle股票0.6%。先鋒集團(Vanguard Group Inc.)目前持有這家特種化學品公司13,661,001股，價值3,021,130,000美元，上個季度又購買了75,867股。貝萊德股份有限公司在第一季度增持了8.8%的Albemarle股票。貝萊德股份有限公司現在持有這家特種化學品公司9924,312股股票，價值2,194,761,000美元，上個季度又購買了803,134股。道富集團在第一季度增持了0.3%的Albemarle股票。道富集團目前持有這家特種化學品公司5,364,655股股票，價值1,188,408,000美元，此前該公司在上個季度又購買了16,968股。Geode Capital Management LLC在第四季度增持了3.4%的Albemarle股票。Geode Capital Management LLC現在擁有這家特種化學品公司2,145,611股股票，價值500,283,000美元，上個季度又購買了71,109股。最後，美國銀行第一季度增持了181.3%的Albemarle股票。美國銀行(Bank Of America Corp DE)目前持有這家特種化學品公司1,489,347股股票，價值329,369,000美元，此前該公司在上季度又購買了959,810股。機構投資者和對衝基金持有該公司80.03%的股票。
About Albemarle
關於Albemarle
(Get Rating)
(獲取評級)
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets.
Albemarle公司在全球範圍內開發、製造和營銷特種化學品。它通過三個部分運行：鋰、溴和催化劑。鋰領域提供鋰化合物，包括碳酸鋰、氫氧化鋰、氯化鋰和特種鋰；以及試劑，如用於消費電子和電動汽車鋰電池的丁基鋰和鋰鋁氫化物、高性能潤滑脂、汽車輪胎用熱塑性彈性體、橡膠鞋底、塑料瓶、化學反應催化劑、類固醇化學和維生素領域的有機合成工藝、生命科學、製藥工業和其他市場。
Featured Stories
專題報道
Get a free copy of the StockNews.com research report on Albemarle (ALB)
Are 3M, Honeywell, GE Buys After Quarterly Reports?
This Defense Stock Has Bullish Fundamentals AND Technicals
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
CVS and Walgreens Show Why Investment Objectives Matter
Are Medtronic And Intuitive Surgical Poised For Big Growth?
免費獲取StockNews.com關於Albemarle的研究報告(ALB)
3M、霍尼韋爾、通用電氣在季度報告後收購嗎？
這隻國防股票的基本面和技術面都看漲
索菲金融股票終於準備好為投資者買單了嗎？
CVS和Walgreens展示為什麼投資目標很重要
美敦力和直覺外科公司準備實現大增長嗎？
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.
接受Albemarle Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收Albemarle和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。